On December 8, 2022, closed the transaction. Starting December 9, 2022, the amount equivalent to 90% of the closing price rounded up to the nearest yen will be If the exercise price exceeds or falls below the immediately preceding effective exercise price by 1 yen or more, the exercise price will be revised to the revised price on or after the revision date. However, if the price after such revision falls below ¥457, the minimum exercise price shall be the revised exercise price.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
380 JPY | -3.80% |
|
-3.55% | -27.20% |
1st Jan change | Capi. | |
---|---|---|
-27.20% | 45.31M | |
+40.80% | 53.67B | |
+34.58% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- 4572 Stock
- News Carna Biosciences, Inc.
- Carna Biosciences, Inc. announced that it has received ¥11.209315 million in funding from Cantor Fitzgerald & Co.